Literature DB >> 32076943

Animal Models of Autoimmune Liver Diseases: a Comprehensive Review.

Shou-Pei Liu1,2, Zhen-Hua Bian1,2,3, Zhi-Bin Zhao1,2, Jinjun Wang4, Weici Zhang5, Patrick S C Leung5, Liang Li6,7, Zhe-Xiong Lian8,9.   

Abstract

Autoimmune liver diseases (AILDs) are potentially life-threatening chronic liver diseases which include autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, and recently characterized IgG4-related sclerosing cholangitis. They are caused by immune attack on hepatocytes or bile ducts, with different mechanisms and clinical manifestations. The etiologies of AILDs include a susceptible genetic background, environment insults, infections, and changes of commensal microbiota, but remain complicated. Understanding of the underlying mechanisms of AILDs is mandatory for early diagnosis and intervention, which is of great importance for better prognosis. Thus, animal models are developed to mimic the pathogenesis, find biomarkers for early diagnosis, and for therapeutic attempts of AILDs. However, no animal models can fully recapitulate features of certain AILD, especially the late stages of diseases. Certain limitations include different living condition, cell composition, and time frame of disease development and resolution. Moreover, there is no IgG4 in rodents which exists in human. Nevertheless, the understanding and therapy of AILDs have been greatly advanced by the development and mechanistic investigation of animal models. This review will provide a comprehensive overview of traditional and new animal models that recapitulate different features and etiologies of distinct AILDs.

Entities:  

Keywords:  Animal models; Autoimmune hepatitis; Autoimmune liver disease; IgG4-related sclerosing cholangitis; Primary biliary cholangitis; Primary sclerosing cholangitis

Year:  2020        PMID: 32076943     DOI: 10.1007/s12016-020-08778-6

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  6 in total

1.  Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition.

Authors:  Hajime Ueda; Akira Honda; Teruo Miyazaki; Yukio Morishita; Takeshi Hirayama; Junichi Iwamoto; Nobuhiro Nakamoto; Tadashi Ikegami
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

Review 2.  The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.

Authors:  Timur Liwinski; Melina Heinemann; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2022-05-10       Impact factor: 11.759

3.  Celastrol Alleviates Autoimmune Hepatitis Through the PI3K/AKT Signaling Pathway Based on Network Pharmacology and Experiments.

Authors:  Shuhui Wang; Zheng Huang; Yu Lei; Xu Han; Dean Tian; Jin Gong; Mei Liu
Journal:  Front Pharmacol       Date:  2022-03-10       Impact factor: 5.810

4.  Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis.

Authors:  Yichen Han; Zhen-Hua Bian; Si-Yu Yang; Cheng-Bo Wang; Liang Li; Yan-Qing Yang; Aftab A Ansari; M Eric Gershwin; Xiaofeng Zeng; Zhe-Xiong Lian; Zhi-Bin Zhao
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

Review 5.  Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

Authors:  Urs Christen; Edith Hintermann
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 6.  Stem cell therapies for autoimmune hepatitis.

Authors:  Ahmed Lotfy; Aya Elgamal; Anna Burdzinska; Ayman A Swelum; Reham Soliman; Ayman A Hassan; Gamal Shiha
Journal:  Stem Cell Res Ther       Date:  2021-07-07       Impact factor: 6.832

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.